phentermine has been researched along with Obesity, Morbid in 12 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present the unique case of a Choctaw lady with morbid obesity who has shown a profound response to pharmacotherapy with phentermine." | 7.75 | A case of profound weight loss secondary to use of phentermine. ( Koch, CA; McDonald, A; Melcescu, E; Uwaifo, GI, 2009) |
| "A 56-week randomized controlled trial was conducted to evaluate safety and efficacy of a controlled-release combination of phentermine and topiramate (PHEN/TPM CR) for weight loss (WL) and metabolic improvements." | 5.16 | Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). ( Allison, DB; Day, WW; Gadde, KM; Garvey, WT; Najarian, T; Peterson, CA; Schwiers, ML; Tam, PY; Troupin, B, 2012) |
| " The USA, the European Union and Norway have approved orlistat, a pancreatic lipase inhibitor for weight reduction for up to two years." | 4.80 | [The obesity epidemics--do diet pills have a place in the treatment?]. ( Birkeland, KI; Tonstad, S, 2000) |
| "Antiobesity drugs orlistat, liraglutide, semaglutide, and phentermine-topiramate vs no treatment." | 4.31 | Cost-Effectiveness of Antiobesity Drugs for Adolescents With Severe Obesity. ( Mital, S; Nguyen, HV, 2023) |
| " We present the unique case of a Choctaw lady with morbid obesity who has shown a profound response to pharmacotherapy with phentermine." | 3.75 | A case of profound weight loss secondary to use of phentermine. ( Koch, CA; McDonald, A; Melcescu, E; Uwaifo, GI, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jayaprakash, MS | 1 |
| Beavers, DP | 1 |
| Miller, GD | 1 |
| McNatt, S | 1 |
| Fernandez, A | 1 |
| Edwards-Hampton, SA | 1 |
| Ard, JD | 1 |
| Mital, S | 1 |
| Nguyen, HV | 1 |
| Cohen, RV | 1 |
| Cummings, DE | 1 |
| Chua, MWJ | 1 |
| Lai, BC | 1 |
| Miras, AD | 1 |
| le Roux, CW | 1 |
| Kalarchian, M | 1 |
| Turk, M | 1 |
| Elliott, J | 1 |
| Gourash, W | 1 |
| Uwaifo, GI | 1 |
| Melcescu, E | 1 |
| McDonald, A | 1 |
| Koch, CA | 1 |
| Delaet, D | 1 |
| Schauer, D | 1 |
| Allison, DB | 1 |
| Gadde, KM | 1 |
| Garvey, WT | 1 |
| Peterson, CA | 1 |
| Schwiers, ML | 1 |
| Najarian, T | 1 |
| Tam, PY | 1 |
| Troupin, B | 1 |
| Day, WW | 1 |
| Raison, CL | 1 |
| Klein, HM | 1 |
| Torretta, LK | 1 |
| Tonstad, S | 1 |
| Birkeland, KI | 1 |
5 reviews available for phentermine and Obesity, Morbid
| Article | Year |
|---|---|
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?
Topics: Anti-Obesity Agents; Bariatric Surgery; Benzazepines; Benzhydryl Compounds; Blood Glucose; Diabetes | 2014 |
Lifestyle management for enhancing outcomes after bariatric surgery.
Topics: Appetite Depressants; Bariatric Surgery; Behavior Therapy; Comorbidity; Diabetes Mellitus, Type 2; D | 2014 |
Obesity in adults.
Topics: Adult; Diethylpropion; Gastric Bypass; Gastroplasty; Humans; Obesity; Obesity, Morbid; Phentermine; | 2011 |
Dexfenfluramine, fenfluramine, and phentermine for the treatment of morbid obesity.
Topics: Appetite Depressants; Fenfluramine; Humans; Obesity, Morbid; Patient Selection; Phentermine | 1997 |
[The obesity epidemics--do diet pills have a place in the treatment?].
Topics: Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Fenfluramine; Humans; Lactones; Leptin; Obe | 2000 |
2 trials available for phentermine and Obesity, Morbid
| Article | Year |
|---|---|
Impact on Cardiovascular Health of Using Phentermine/Topiramate in Combination With Laparoscopic Sleeve Gastrectomy in Super Obesity.
Topics: Antihypertensive Agents; Gastrectomy; Humans; Laparoscopy; Obesity; Obesity, Morbid; Phentermine; Re | 2023 |
Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).
Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Blood Glucose; Blood Pressure; Body Weight; Delayed-Ac | 2012 |
5 other studies available for phentermine and Obesity, Morbid
| Article | Year |
|---|---|
Cost-Effectiveness of Antiobesity Drugs for Adolescents With Severe Obesity.
Topics: Adolescent; Anti-Obesity Agents; Child; Cost-Benefit Analysis; Female; Humans; Liraglutide; Male; Ob | 2023 |
Weight Regain After Bariatric/Metabolic Surgery: A Wake-Up Call.
Topics: Bariatric Surgery; Gastric Bypass; Humans; Obesity, Morbid; Phentermine; Topiramate; Weight Gain | 2020 |
Phentermine-Induced Acute Kidney Injury Secondary to Uncontrolled Hypertension in a Patient with Weight Regain Post-bariatric Surgery.
Topics: Acute Kidney Injury; Bariatric Surgery; Humans; Hypertension; Obesity, Morbid; Phentermine; Weight G | 2021 |
A case of profound weight loss secondary to use of phentermine.
Topics: Adult; Appetite Depressants; Body Mass Index; Diabetes Mellitus, Type 2; Dose-Response Relationship, | 2009 |
Psychotic mania associated with fenfluramine and phentermine use.
Topics: 1-Naphthylamine; Bipolar Disorder; Depressive Disorder; Female; Fenfluramine; Humans; Middle Aged; O | 1997 |